You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 005213


✉ Email this page to a colleague

« Back to Dashboard


NDA 005213 describes HYCODAN, which is a drug marketed by Genus and is included in one NDA. It is available from two suppliers. Additional details are available on the HYCODAN profile page.

The generic ingredient in HYCODAN is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.
Summary for 005213
Tradename:HYCODAN
Applicant:Genus
Ingredient:homatropine methylbromide; hydrocodone bitartrate
Patents:0
Pharmacology for NDA: 005213
Mechanism of ActionOpioid Agonists
Suppliers and Packaging for NDA: 005213
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYCODAN homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 005213 NDA AUTHORIZED GENERIC PAI Holdings, LLC dba PAI Pharma 0121-1036 0121-1036-40 4 TRAY in 1 CASE (0121-1036-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1036-05)
HYCODAN homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 005213 NDA Genus Lifesciences Inc. 64950-205 64950-205-03 30 TABLET in 1 BOTTLE, PLASTIC (64950-205-03)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Jul 26, 1988TE:AARLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrength1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Jul 26, 1988TE:AARLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.